GGrantIndex
Sort

85,873 grants matching alzheimers

New DNA methylation biomarkers for predicting AD and cognitive decline

$746,561
Lily Wang · University Of Miami School Of Medicine · R61 · FY2025 · NS

Circulating factors mediating systemic bioenergetic capacity in the pathogenesis and treatment of Alzheimer's Disease

$746,527
Anthony J Molina · University Of California, San Diego · R56 · FY2018 · AG

Involving Family to Improve Advance Care Planning for Primary Care Patients with ADRD

$746,493
Jennifer L Wolff · Johns Hopkins University · R01 · FY2023 · AG

Environmental factors in pathobiology of dementia: the role of PCB exposure, microbiome, and tissue barrier dysfunction

$746,440
Hans-Joachim Lehmler · University Of Iowa · R01 · FY2023 · ES

NEUROIMAGING ANALYSIS CENTER

$746,435
Brigham And Women'S Hospital · P41 · FY2001 · RR

Synaptic Plasticity In Aging And Neurodegenerative Disorders

$746,422
Mark Mattson · National Institute On Aging · ZIA · FY2011 · AG

Cellular And Molecular Pathogenesis Of Alzheimer

$746,422
Mark Mattson · National Institute On Aging · ZIA · FY2011 · AG

Head-to-head comparisons of high-performance plasma phospho-tau epitopes for the detection of Alzheimer's disease

$746,421
Tharick Pascoal · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG

Head-to-head comparisons of high-performance plasma phospho-tau epitopes for the detection of Alzheimer's disease

$746,421
Tharick Pascoal · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG

PREVENTABLE Administrative and Trial Management

$746,412
Karen P Alexander · Duke University · U19 · FY2024 · AG

Neural Correlates and Modifiers of Cognitive Aging

$746,399
Naftali Raz · Wayne State University · R01 · FY2016 · AG

THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE

$746,361
Amanda J Myers · University Of Miami School Of Medicine · R01 · FY2024 · AG

Aerobic Glycolysis in the Development ofAlzheimer's Disease

$746,358
Andrei G. Vlassenko · Washington University · R01 · FY2019 · AG

Acceleration of Circulatory and Neurological Aging due to Wildfire Exposures

$746,328
Matthew J Campen · University Of New Mexico Health Scis Ctr · R01 · FY2024 · AG

Lead Optimization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease

$746,325
Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2017 · AG

Brain networks in mouse models of aging

$746,304
Alexandra Badea · Duke University · R01 · FY2021 · AG

Inclusion of Under-Represented Groups Core

$746,287
Carey E Gleason · University Of Wisconsin-Madison · P30 · FY2021 · AG

Randomized Clinical Trial of a Brief, Anxiety Intervention for Mild Cognitive Impairment/mild Alzheimer’s Disease and their Care Providers

$746,255
Norman Brad Schmidt · Florida State University · R01 · FY2024 · AG

Deciphering the role of CX3CR1 in Modulating Mechanisms of Amyloid driven Neurodegeneration in Alzheimer's Disease

$746,243
Bruce T Lamb · Indiana University Indianapolis · R01 · FY2024 · AG

Clinical Core

$746,237
Liana G Apostolova · Indiana University Indianapolis · P30 · FY2021 · AG

Alzheimer's Disease Neuroimaging Initiative

$746,232
Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2020 · AG

Defining molecular contributions of LINE-1 retrotransposons to AD / ADRD

$746,218
John Lacava · Rockefeller University · R01 · FY2023 · AG

Defining molecular contributions of LINE-1 retrotransposons to AD / ADRD

$746,218
John Lacava · Rockefeller University · R01 · FY2024 · AG

Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists

$746,208
Konrad Talbot · Loma Linda University · R01 · FY2019 · AG

Health Literacy and Cognitive Function among Middle-Aged Adults: The MidCog Study

$746,203
Michael S Wolf · Northwestern University At Chicago · R01 · FY2023 · AG